相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis
Marcello Tonelli et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
Julia Bohlius et al.
LANCET (2009)
Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells
A. M. Sinclair et al.
BRITISH JOURNAL OF CANCER (2008)
Effect of treatment with epoetin-β on survival, tumour progression and thromboembolic events in patients with cancer:: an updated meta-analysis of 12 randomised controlled studies including 2301 patients
M. Aapro et al.
BRITISH JOURNAL OF CANCER (2008)
Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients
Ryan D. Kilpatrick et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer
Gillian Thomas et al.
GYNECOLOGIC ONCOLOGY (2008)
Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer
H. -G. Strauss et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Erythropoiesis-Stimulating Agents in the Treatment of Cancer-Associated Anemia—Reply
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Erythropoiesis-Stimulating Agents in the Treatment of Cancer-Associated Anemia
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
Charles L. Bennett et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: Results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study
Matti Aapro et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Darbepoetin alfa for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study
Robert E. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Safety and efficacy of darbepoetin alfa in previously untreated extensive-stage small-cell lung cancer treated with platinum plus etoposide
Robert Pirker et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alfa administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia
Laurent Bastit et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Lack of functional erythropoietin receptors of cancer cell lines
Magdalena Laugsch et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: A randomized trial of the radiation therapy oncology group (RTOG 99-03)
Mitchell Machtay et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Medical and economic impact of anemia in hospitalized patients
Richard K. Spence
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Medical and economic impact of anemia in hospitalized patients
Richard K. Spence
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Expression and function of erythropoietin receptors in tumors - Implications for the use of erythropoiesis-stimulating agents in cancer patients
Angus M. Sinclair et al.
CANCER (2007)
Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia
James R. Wright et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Erythropoietin receptor expression in non-small cell lung carcinoma: A question of antibody specificity
W. Mark Brown et al.
STEM CELLS (2007)
Anemia in patients with cancer: Incidence, causes, impact, management, and use of treatment guidelines and protocols
Rowena N. Schwartz
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Preclinical studies of erythropoietin receptor expression in tumour cells:: Impact on clinical use of erythropoietic proteins to correct cancer-related anaemia
Anders Osterborg et al.
EUROPEAN JOURNAL OF CANCER (2007)
Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: A controlled, randomized, open-label phase II trial
Veena Charu et al.
ONCOLOGIST (2007)
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer:: 2006 update
C. Bokemeyer et al.
EUROPEAN JOURNAL OF CANCER (2007)
Randomized study of the importance of Novel Erythropoiesis Stimulating Protein (Aranesp (R)) for the effect of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) - the Danish Head and Neck Cancer Group DAHANCA 10 randomized trial
J. Overgaard et al.
EJC SUPPLEMENTS (2007)
Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer:: a meta-analysis
M. Aapro et al.
BRITISH JOURNAL OF CANCER (2006)
Correction of anemia with epoetin alfa in chronic kidney disease
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy
Bassem I. Razzouk et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial
PM Wilkinson et al.
BRITISH JOURNAL OF CANCER (2006)
Anti-Epo receptor antibodies do not predict Epo receptor expression
S Elliott et al.
BLOOD (2006)
Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells
L Feldman et al.
PROSTATE (2006)
Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: A systematic review of the literature
Susan D. Ross et al.
CLINICAL THERAPEUTICS (2006)
Efficacy and safety analysis of epoetin alfa in patients with small-cell lung cancer: A randomized, double-blind, placebo-controlled trial
T Grote et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Darbepoetin alfa for the treatment of chemotherapy-induced anemia: Disease progression and survival analysis from four randomized double-blind placebo-controlled trails
M Hedenus et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial
JH Savonije et al.
EUROPEAN JOURNAL OF CANCER (2005)
Impact of maintaining Hb with epoetin alfa on time to progression (TTP), overall survival (OS), quality of life (QOL) and transfusion reduction in limited disease SCLC patients
G Goss et al.
LUNG CANCER (2005)
Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma
SY Lai et al.
ONCOGENE (2005)
Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy
J Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy
TE Witzig et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Impact of epoetin-β on survival of patients with lymphoproliferative malignancies:: long-term follow up of a large randomized study
A Österborg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
B Leyland-Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prevalence and outcomes of anemia in cancer: A systematic review of the literature
K Knight et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial
M Auerbach et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The rationale for pathogen-inactivation treatment of blood components
JAJ Barbara
INTERNATIONAL JOURNAL OF HEMATOLOGY (2004)
The European Cancer Anaemia Survey (ECAS):: A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients
H Ludwig et al.
EUROPEAN JOURNAL OF CANCER (2004)
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:: randomised, double-blind, placebo-controlled trial
M Henke et al.
LANCET (2003)
Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study
D Kotasek et al.
EUROPEAN JOURNAL OF CANCER (2003)
Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies:: a randomized, double-blind, placebo-controlled study
M Hedenus et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
A dose- and schedule-finding study of darbepoetin alpha for the treatment of chronic anaemia of cancer
RE Smith et al.
BRITISH JOURNAL OF CANCER (2003)
Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes
D Cella et al.
ANNALS OF ONCOLOGY (2003)
Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human erythropoietin (rHuEpo): A prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group
A Bamias et al.
ONCOLOGY (2003)
Randomized, dose-finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies
M Hedenus et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Cancer and thromboembolic disease: pathogenic mechanisms
AY Lee
CANCER TREATMENT REVIEWS (2002)
Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma
F Dammacco et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Erythropoietin stimulates proliferation of human renal carcinoma cells
C Westenfelder et al.
KIDNEY INTERNATIONAL (2000)
Quantitative expression of erythropoietin receptor (EPO-R) on acute leukaemia cells: relationships between the amount of EPO-R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosis
A Takeshita et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
分享论文
